BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9222087)

  • 1. Cidofovir transport in the pigmented rabbit conjunctiva.
    Hosoya K; Lee VH
    Curr Eye Res; 1997 Jul; 16(7):693-7. PubMed ID: 9222087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin transport and metabolism in the pigmented rabbit conjunctiva.
    Sun L; Basu SK; Kim KJ; Lee VH
    Eur J Pharm Sci; 1998 Jan; 6(1):47-52. PubMed ID: 16256707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na(+)-dependent L-arginine transport in the pigmented rabbit conjunctiva.
    Hosoya K; Horibe Y; Kim KJ; Lee VH
    Exp Eye Res; 1997 Oct; 65(4):547-53. PubMed ID: 9464187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog.
    Aspe E; Guy RH; Lee WA; Kennedy JA; Visor GC; Ennis RD
    J Pharm Sci; 1995 Jun; 84(6):750-4. PubMed ID: 7562417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva.
    Horibe Y; Hosoya K; Kim KJ; Lee VH
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1436-43. PubMed ID: 9660492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
    Cundy KC; Li ZH; Lee WA
    Drug Metab Dispos; 1996 Mar; 24(3):315-21. PubMed ID: 8820422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of organic cation drug transport in the pigmented rabbit conjunctiva.
    Ueda H; Horibe Y; Kim KJ; Lee VH
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):870-6. PubMed ID: 10711706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialized protective role of mucosal glutathione in pigmented rabbit conjunctiva.
    Gukasyan HJ; Kim KJ; Kannan R; Farley RA; Lee VH
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4427-38. PubMed ID: 14507889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
    Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
    Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and metabolism of cidofovir following topical administration to rabbits.
    Cundy KC; Lynch G; Lee WA
    Antiviral Res; 1997 Jul; 35(2):113-22. PubMed ID: 9217248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cidofovir in both skin layers and percutaneous penetration samples by HPLC.
    Santoyo S; de Jalón EG; Campanero MA; Ygartua P
    J Pharm Biomed Anal; 2002 Jul; 29(5):819-26. PubMed ID: 12093514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic evidence for Na(+)-glucose co-transport in the pigmented rabbit conjunctiva.
    Horibe Y; Hosoya K; Kim KJ; Lee VH
    Curr Eye Res; 1997 Oct; 16(10):1050-5. PubMed ID: 9330858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
    Ashton P; Podder SK; Lee VH
    Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC.
    Kim JW; el-Haig W; Capparelli EV; Besen G; Connor JD; Freeman WR
    Retina; 1995; 15(6):513-7. PubMed ID: 8747447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside transport mechanisms in the pigmented rabbit conjunctiva.
    Hosoya K; Horibe Y; Kim KJ; Lee VH
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):372-7. PubMed ID: 9477996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polar solute transport across the pigmented rabbit conjunctiva: size dependence and the influence of 8-bromo cyclic adenosine monophosphate.
    Horibe Y; Hosoya K; Kim KJ; Ogiso T; Lee VH
    Pharm Res; 1997 Sep; 14(9):1246-51. PubMed ID: 9327456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).
    Lalezari JP; Stagg RJ; Jaffe HS; Hitchcock MJ; Drew WL
    Adv Exp Med Biol; 1996; 394():105-15. PubMed ID: 8815677
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
    Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
    Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
    Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.
    Cundy KC; Li ZH; Hitchcock MJ; Lee WA
    Drug Metab Dispos; 1996 Jul; 24(7):738-44. PubMed ID: 8818570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.